# Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

> **NCT05500391** · PHASE2 · RECRUITING · sponsor: **Centre Oscar Lambret** · enrollment: 88 (estimated)

## Conditions studied

- Stage I Testicular Seminoma
- Stage I Testicular Nonseminomatous Germ Cell Tumor
- Gastrointestinal Stromal Tumors
- Ovarian Germ Cell Tumor
- Adenocarcinoma, Clear Cell
- Borderline Ovarian Tumor
- Sex Cord-Stromal Tumor
- Mucinous Adenocarcinoma of Ovary
- Carcinoma, Small Cell
- Carcinosarcoma, Ovarian
- Serous Tumor of Ovary
- Glioma
- Neuroendocrine Tumors
- Aggressive Fibromatosis of Abdominal Wall (Disorder)

## Interventions

- **OTHER:** Oncological Follow-up

## Key facts

- **NCT ID:** NCT05500391
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-28
- **Primary completion:** 2026-10
- **Final completion:** 2032-07
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05500391

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05500391, "Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05500391. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*